ACP5 and breast carcinoma: In breast cancer-related studies, the TRAP/ACP5/uteroferrin/purple acid phosphatase/PP5 signaling axis can act as a driver mediating breast cancer invasion and mediate cancer malignant progression at the cellular level (Krumpel et al., 2015).